Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

RaQualia Pharma

Sosei Group

日本化学工業

NIPPON SEIRO

KAWAKAMI PAINT MFG.

Miyoshi Oil & Fat

Nippon Shikizai

本州化学工業

CO-OP CHEMICAL

Chiome Bioscience

シンバイオ製薬

TAOKA CHEMICAL

CHISSO

Carna Biosciences

Kawaguchi Chemical Industry

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

NIPPON COKE & ENGINEERING

PIONEER

Nissan Motor

Yushiro Chemical Indutry

NITCHITSU　

Financial Indicator Details: Chiome Bioscience (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: Chiome Bioscience (Annual )

Non-Consolidated :Indicator Non-Consolidated

Profitability	2012-03-31	2013-03-31
Net profit margin (Industry Average)	-6.95% (-10.69%)	-131.48% (8.92%)
C/F margin (Industry Average)	-7.58% (-0.81%)	-115.12% (-39.63%)
ROA (Industry Average)	-3.47% (-0.27%)	-32.87% (1.53%)
ROE (Industry Average)	-4.21% (3.42%)	-41.08% (2.62%)
Growth	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (0.04%)	-0.76% (3.91%)
Sales growth (Industry Average)	- (-)	-48.81% (-1.74%)
Net profit growth (Industry Average)	- (-47.04%)	-868.18% (62.14%)
Operating C/F growth (Industry Average)	- (-44.41%)	-677.08% (46.89%)
Stability	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	82.55% (55.93%)	80.01% (57.57%)
Liquidity ratio (Industry Average)	517.68% (314.47%)	455.75% (233.84%)
C/F ratio current liabilities (Industry Average)	-441.26% (76.77%)	-63.81% (31.87%)
Quick ratio (Industry Average)	501.81% (228.06%)	435.34% (169.77%)
Turnover	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	28.71day (98.58day)	53.73day (67.18day)
Inventory turnover (Industry Average)	11.12day (50.67day)	24.67day (38.21day)
Payable turnover (Industry Average)	9.30day (53.57day)	24.76day (34.24day)
Working capita turnover (Industry Average)	30.53day (95.69day)	53.64day (71.15day)
Stock etc.	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-3.30%)	806.69% (24.19%)
Dividend Yield (Industry Average)	- (0.16%)	- (0.15%)
PER (Industry Average)	-101.79% (22.26%)	-95.33% (26.42%)
PBR (Industry Average)	4.28% (1.08%)	39.16% (1.54%)
PCFR (Industry Average)	-93.31% (0.08%)	-108.87% (4.97%)
PSR (Industry Average)	7.07% (4.37%)	125.34% (10.14%)

Financial Indicator Details: Chiome Bioscience

Non-Consolidated :Indicator Non-Consolidated

Indicator	2012-03-31	2013-03-31
Profitability
Net profit margin	-6.95%	-131.48%
C/F margin	-7.58%	-115.12%
ROA	-3.47%	-32.87%
ROE	-4.21%	-41.08%
Recurring margin	-6.63%	-130.86%
EBIT margin	-6.49%	-130.50%
EBITDA margin	2.48%	-113.38%
NOPAT margin	-3.89%	-78.30%
Sales SG rates	33.71%	36.85%
Sales SG&A rates	67.46%	190.70%
Sales R&D expenses rates	-	-
Sales depreciation rates	8.97%	17.11%
Capital expenditures net sales ratio	-0.59%	-13.21%
Indicator	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-2.42%
Equity growth	-	-0.76%
Total assets growth	-	2.38%
Sales growth	-	-48.81%
Net profit growth	-	-868.18%
Operating C/F growth	-	-677.08%
Recurring profit growth	-	-909.52%
EBIT growth	-	-929.03%
EBITDA growth	-	-2,436.92%
NOPAT growth	-	-929.03%
Operating expenses growth	-	-
Indicator	2012-03-31	2013-03-31
Stability
Capital adequacy	82.55%	80.01%
Liquidity ratio	517.68%	455.75%
C/F ratio current liabilities	-441.26%	-63.81%
Quick ratio	501.81%	435.34%
Fixed ratio	13.92%	11.31%
D/E ratio	8.05%	12.73%
Loan to Value Ratio	6.64%	10.19%
Business investment C/F ratio	7.83%	11.47%
Liabilities with interest growth	-	56.93%
Indicator	2012-03-31	2013-03-31
Turnover
Cash turnover	584.16day	1,113.62day
Receivables turnover	28.71day	53.73day
Inventory turnover	11.12day	24.67day
Fixed assets turnover	83.91day	132.13day
Total asset turnover	729.92day	1,460.00day
Payable turnover	9.30day	24.76day
Capital turnover	592.76day	1,366.59day
Equity turnover	602.56day	1,168.22day
Working capita turnover	30.53day	53.64day
Indicator	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 1 B	¥ 988 M
Accounts receivable-trade	¥ 49 M	¥ 47 M
Other Current Assets	¥ 83 M	¥ 96 M
Current Assets	¥ 1 B	¥ 1 B
Tangible Assets	¥ 145 M	¥ 117 M
Intangible Assets	¥ 9 M	¥ 9 M
Investment etc.	¥ 14 M	¥ 84 M
Total Assets	¥ 1 B	¥ 1 B
Current Liabilities	¥ 211 M	¥ 238 M
Fixed Liabilities	¥ 8 M	¥ 20 M
Liabilities with interest	¥ 84 M	¥ 132 M
Net Assets	¥ 1 B	¥ 1 B
Capital stock	¥ 1 B	¥ 1 B
Capital surplus etc.	¥ 17 M	¥ -176 M
Liabilities and net assets	¥ 1 B	¥ 1 B
Indicator	2012-03-31	2013-03-31
Income statement
Sales	¥ 633 M	¥ 324 M
Cost of Sales	¥ 213 M	¥ 119 M
Gross profit	¥ 419 M	¥ 204 M
Other income	¥ 1 M	¥ 902 K
SG&A	¥ 427 M	¥ 617 M
Other expenses	¥ 38 M	¥ 14 M
Net income	¥ -44 M	¥ -426 M
Operating income	¥ -7 M	¥ -413 M
Ordinary Income	¥ -42 M	¥ -424 M
EBITDA	¥ 15 M	¥ -367 M
Income before income taxes	¥ -42 M	¥ -424 M
Depreciation	¥ 56 M	¥ 55 M
R&D expenses	-	-
Income taxes	¥ 1 M	¥ 2 M
Indicator	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ -48 M	¥ -373 M
Investment CF	¥ -3 M	¥ -114 M
Financial CF	¥ 419 M	¥ 463 M
Foreign Exchange Effects	-	¥ 20 K
Net Change in Cash	¥ 366 M	¥ -24 M
Free CF	¥ -51 M	¥ -487 M
Capital expenditures	¥ -3 M	¥ -42 M
Cash dividends paid	-	-
Repayment loans	¥ -120 M	¥ -102 M
Indicator	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	¥ 496 M	¥ 370 M
Dividends from surplus	-	-
Net income	¥ -44 M	¥ -426 M
Purchase of treasury stock	-	-
Other Change in Stockholders Equity	¥ -1 K	-
Other Change in Net Assets	-	¥ 49 M
Net Change in Net Assets	¥ 452 M	¥ -7 M

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Chiome Bioscience (Annual )

Statement Type

Annual : Chiome Bioscience

First quarter : Chiome Bioscience

Second quarter : Chiome Bioscience

Third quarter : Chiome Bioscience

Analysis Menu

Outline : Chiome Bioscience

Statement : Chiome Bioscience

Rating : Chiome Bioscience

Indicator : Chiome Bioscience

Download : Chiome Bioscience

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo新宿区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
Chiome Bioscience	4583	TSE Mothers	Chemicals	3	Annual	BB

Related Company

CHISSO (Sales -)

廣貫堂 (Sales ¥ 10 B)

Sosei Group (Sales -)

KAWAKAMI PAINT MFG. (Sales ¥ 5 B)

Nippon Pigment (Sales ¥ 23 B)

Nippon Shikizai (Sales ¥ 6 B)

本州化学工業 (Sales ¥ 13 B)

Chiome Bioscience (Sales ¥ 324 M)

CO-OP CHEMICAL (Sales ¥ 20 B)

RaQualia Pharma (Sales ¥ 28 M)

TAOKA CHEMICAL (Sales ¥ 16 B)

NIPPON SEIRO (Sales ¥ 40 B)

関東電化工業 (Sales ¥ 30 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .